Effect of R-(-)-deprenyl and harmaline on dopamine- and peroxynitrite-induced membrane permeability transition in brain mitochondria
DC Field | Value | Language |
---|---|---|
dc.contributor.author | Lee, Chung Soo | - |
dc.contributor.author | Lee, Chung Seok | - |
dc.contributor.author | Ko, Hyun Hee | - |
dc.contributor.author | Song, Jin Ho | - |
dc.contributor.author | Han, Eun Sook | - |
dc.date.available | 2019-05-30T09:37:22Z | - |
dc.date.issued | 2002-03 | - |
dc.identifier.issn | 0364-3190 | - |
dc.identifier.issn | 1573-6903 | - |
dc.identifier.uri | https://scholarworks.bwise.kr/cau/handle/2019.sw.cau/25138 | - |
dc.description.abstract | The present study examined the effect of MAO inhibitors, deprenyl and harmaline, on the membrane permeability transition in brain mitochondria. Deprenyl, harmaline, and antioxidant enzymes (SOD and catalase) attenuated alteration of the swelling, membrane potential, cytochrome c release, and Ca2+ transport in mitochondria treated with dopamine. In contrast, deprenyl and harmaline did not reduce the peroxynitrite-induced change in membrane permeability. Deprenyl and harmaline inhibited the decrease in thioredoxin reductase activity and the thiol oxidation in mitochondria treated with dopamine but did not decrease the effect of peroxynitrite. Deprenyl and harmaline significantly decreased the formation of melanin from dopamine. The results suggest that deprenyl and harmaline may protect brain mitochondria against the toxic action of dopamine oxidation by the maintenance of thioredoxin reductase activity, inhibition of thiol oxidation, and inhibition of dopamine oxidation product formation. In contrast, MAO inhibitors may not defend brain mitochondria against damaging action of peroxynitrite. | - |
dc.format.extent | 10 | - |
dc.language | 영어 | - |
dc.language.iso | ENG | - |
dc.publisher | SPRINGER/PLENUM PUBLISHERS | - |
dc.title | Effect of R-(-)-deprenyl and harmaline on dopamine- and peroxynitrite-induced membrane permeability transition in brain mitochondria | - |
dc.type | Article | - |
dc.identifier.doi | 10.1023/A:1014832520809 | - |
dc.identifier.bibliographicCitation | NEUROCHEMICAL RESEARCH, v.27, no.3, pp 215 - 224 | - |
dc.description.isOpenAccess | N | - |
dc.identifier.wosid | 000174854100006 | - |
dc.identifier.scopusid | 2-s2.0-0036203428 | - |
dc.citation.endPage | 224 | - |
dc.citation.number | 3 | - |
dc.citation.startPage | 215 | - |
dc.citation.title | NEUROCHEMICAL RESEARCH | - |
dc.citation.volume | 27 | - |
dc.type.docType | Article | - |
dc.publisher.location | 미국 | - |
dc.subject.keywordAuthor | R-(-)-deprenyl | - |
dc.subject.keywordAuthor | harmaline | - |
dc.subject.keywordAuthor | dopamine | - |
dc.subject.keywordAuthor | peroxynitrite | - |
dc.subject.keywordAuthor | mitochondrial dysfunction | - |
dc.subject.keywordPlus | NITRIC-OXIDE SYNTHASE | - |
dc.subject.keywordPlus | CYTOCHROME-C RELEASE | - |
dc.subject.keywordPlus | NEUROBLASTOMA SH-SY5Y CELLS | - |
dc.subject.keywordPlus | PARKINSONS-DISEASE | - |
dc.subject.keywordPlus | PC12 CELLS | - |
dc.subject.keywordPlus | GLUTAMATE NEUROTOXICITY | - |
dc.subject.keywordPlus | LIVER-MITOCHONDRIA | - |
dc.subject.keywordPlus | OXIDATIVE STRESS | - |
dc.subject.keywordPlus | APOPTOSIS | - |
dc.subject.keywordPlus | INHIBITION | - |
dc.relation.journalResearchArea | Biochemistry & Molecular Biology | - |
dc.relation.journalResearchArea | Neurosciences & Neurology | - |
dc.relation.journalWebOfScienceCategory | Biochemistry & Molecular Biology | - |
dc.relation.journalWebOfScienceCategory | Neurosciences | - |
dc.description.journalRegisteredClass | scie | - |
dc.description.journalRegisteredClass | scopus | - |
Items in ScholarWorks are protected by copyright, with all rights reserved, unless otherwise indicated.
84, Heukseok-ro, Dongjak-gu, Seoul, Republic of Korea (06974)02-820-6194
COPYRIGHT 2019 Chung-Ang University All Rights Reserved.
Certain data included herein are derived from the © Web of Science of Clarivate Analytics. All rights reserved.
You may not copy or re-distribute this material in whole or in part without the prior written consent of Clarivate Analytics.